Table 2.
AGI | AGI without respiratory symptoms | |||||||
---|---|---|---|---|---|---|---|---|
Adjusted monthly prevalence (%) | 95% CI | Annual incidence per person-year | 95% CI | Adjusted monthly prevalence (%) | 95% CI | Annual incidence per person-year | 95% CI | |
Overall province | 5.7 | 4.6–7.2 | 0.77 | 0.61–0.97 | 4.3 | 3.1–5.8 | 0.57 | 0.41–0.78 |
BC | 6.8 | 4.3–10.8 | 0.92 | 0.57–1.49 | 4.5 | 2.5–7.8 | 0.59 | 0.33–1.06 |
AB | 7.6 | 4.9–11.6 | 1.03 | 0.65–1.61 | 4.7 | 3.0–7.3 | 0.62 | 0.40–0.99 |
SK | 4.6 | 2.8–7.3 | 0.61 | 0.37–0.99 | 2.4 | 1.6–3.5 | 0.31 | 0.21–0.46 |
MB | 9.2 | 4.8–17.0 | 1.26 | 0.64–2.42 | 7.9 | 3.7–16.3 | 1.07 | 0.49–2.31 |
ON | 5.8 | 3.6–9.3 | 0.78 | 0.48–1.27 | 4.7 | 2.5–8.7 | 0.63 | 0.33–1.19 |
QC | 3.4 | 2.1–5.4 | 0.45 | 0.28–0.72 | 2.8 | 1.6–4.9 | 0.37 | 0.21–0.65 |
NB | 6.9 | 4.4–10.7 | 0.94 | 0.59–1.47 | 3.5 | 1.8–6.5 | 0.46 | 0.24–0.88 |
NS | 6.5 | 4.4–9.3 | 0.87 | 0.59–1.27 | 5.1 | 3.5–7.8 | 0.68 | 0.46–1.06 |
PE | 6.3 | 3.2–11.9 | 0.84 | 0.42–1.65 | 4.1 | 2.9–8.8 | 0.55 | 0.38–1.20 |
NL | 7.9 | 4.6–13.3 | 1.08 | 0.61–1.86 | 6.6 | 3.5–12.1 | 0.89 | 0.46–1.68 |
YT | 8.9 | 4.4–17.3 | 1.22 | 0.59–2.47 | 5.2 | 2.9–9.2 | 0.69 | 0.38–1.26 |
NT | 7.4 | 4.3–12.6 | 1.01 | 0.57–1.75 | 5.6 | 2.9–10.6 | 0.75 | 0.38–1.46 |
NU | 9.9 | 5.3–17.9 | 1.36 | 0.71–2.56 | 5.4 | 2.2–12.6 | 0.72 | 0.29–1.75 |
Bold indicates monthly prevalence per category level significantly different from all other categories combined.